Tilray Brands, Inc. (TLRY)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$6.59
-4.35%
Mkt Cap $786.71M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 1, 2026 | $201.35M | $206.73M | +2.67% | -$0.14 | -$0.24 | -71.43% | — | — |
| Q1 2026 Jan 8, 2026 | $210.94M | $217.51M | +3.11% | -$0.14 | -$0.41 | -192.86% | — | — |
| Q4 2025 Oct 9, 2025 | $204.55M | $287.78M | +40.69% | -$0.27 | -$0.00 | +98.43% | — | — |
| Q3 2025 Jul 28, 2025 | $208.50M | $224.46M | +7.66% | -$0.03 | $0.02 | +166.67% | — | — |
| Q2 2025 Apr 8, 2025 | $249.71M | $185.78M | -25.60% | -$0.04 | -$0.10 | -150.00% | — | — |
| Q1 2025 Jan 10, 2025 | $216.33M | $210.95M | -2.49% | -$0.04 | -$0.10 | -150.00% | — | — |
| Q4 2024 Oct 10, 2024 | $218.70M | $200.04M | -8.53% | -$0.04 | -$0.04 | -11.11% | — | — |
| Q3 2024 Jul 29, 2024 | $227.07M | $229.75M | +1.18% | -$0.02 | -$0.04 | -81.82% | — | — |
| Q2 2024 Apr 9, 2024 | $225.25M | $188.30M | -16.40% | -$0.05 | -$0.12 | -140.00% | — | — |
| Q1 2024 Jan 9, 2024 | $195.10M | $193.52M | -0.81% | -$0.06 | -$0.07 | -11.63% | — | — |
| Q4 2023 Oct 4, 2023 | $173.51M | $176.82M | +1.91% | -$0.05 | -$0.10 | -100.00% | — | — |
| Q3 2023 Jul 26, 2023 | $153.66M | $183.84M | +19.64% | -$0.05 | -$0.15 | -200.00% | — | — |
| Q2 2023 Apr 10, 2023 | $202.47M | $145.50M | -28.13% | -$0.05 | -$0.04 | +20.00% | — | — |
| Q1 2023 Jan 9, 2023 | $154.79M | $144.14M | -6.88% | -$0.05 | -$0.06 | -20.00% | — | — |
| Q4 2022 Oct 7, 2022 | $155.87M | $153.12M | -1.76% | -$0.06 | -$0.08 | -33.33% | — | — |
| Q3 2022 Jul 28, 2022 | $151.26M | $153.29M | +1.34% | -$0.07 | -$0.34 | -385.71% | — | — |
| Q2 2022 Apr 6, 2022 | $156.16M | $151.35M | -3.08% | -$0.08 | $0.04 | +150.00% | — | — |
| Q1 2022 Jan 10, 2022 | $243.13M | $154.99M | -36.25% | -$0.09 | $0.03 | +133.33% | — | — |
| Q4 2021 Oct 7, 2021 | $179.33M | $167.94M | -6.35% | -$0.07 | -$0.08 | -14.29% | — | — |
| Q3 2021 Jul 28, 2021 | $180.46M | $152.14M | -15.69% | -$0.08 | -$0.11 | -37.50% | — | — |